Cristina Mezzanotte
Overview
Explore the profile of Cristina Mezzanotte including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Danieli M, Mezzanotte C, Verga J, Menghini D, Pedini V, Bilo M, et al.
Biomedicines
. 2022 Mar;
10(3).
PMID: 35327437
Background: Common variable immunodeficiency (CVID) is a complex, predominantly antibody deficiency usually diagnosed between 20−40 years. Few data about elderly patients are reported in the literature. Our aim was to...
2.
Danieli M, Verga J, Mezzanotte C, Terrenato I, Svegliati S, Bilo M, et al.
Front Immunol
. 2022 Feb;
12:805705.
PMID: 35111165
Background: Immunoglobulin (Ig) replacement therapy represents a life-saving treatment in primary antibody deficiencies. The introduction of subcutaneous Ig (SCIg) administration brings a major improvement in quality of life for patients,...
3.
Danieli M, Piga M, Paladini A, Longhi E, Mezzanotte C, Moroncini G, et al.
Scand J Immunol
. 2021 Dec;
94(5):e13101.
PMID: 34940980
The coronavirus disease-19 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) challenged globally with its morbidity and mortality. A small percentage of affected patients (20%) progress into...
4.
Pedini V, Verga J, Terrenato I, Menghini D, Mezzanotte C, Danieli M
Allergy Asthma Clin Immunol
. 2020 Sep;
16:54.
PMID: 32944022
Background: Common variable immunodeficiency (CVID) is the most common symptomatic primary immunodeficiency and has a broad spectrum of clinical manifestations. Among non-infectious complications, an increased incidence of malignancies may have...
5.
Danieli M, Menghini D, Mezzanotte C, Gelardi C, Pedini V, Monteforte F
Isr Med Assoc J
. 2019 Sep;
21(7):494-496.
PMID: 31507128
No abstract available.